Internal Medicine · Iowa City, IA
NPI
1063824639
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
200 Hawkins Dr, Department of Internal Medicine
Iowa City, IA, 52242
Phone (319) 384-9668
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
931 services
Medicare patients, 2024
410
Average age 80
Drug cost, 2024
$1.0M
14,933 prescriptions
Company payments, 2025
$87.49
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Desire T Gijima was code 99309 (snf e&m), 333 times for 184 patients. In total Desire T Gijima billed 931 services in 8 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99309 SNF E&M | Office | 333 | 184 | $71.31 | $24K |
| 99306 SNF E&M | Facility | 200 | 175 | $128.86 | $26K |
| 99310 SNF E&M | Office | 112 | 84 | $104.29 | $12K |
| 99306 SNF E&M | Office | 103 | 98 | $127.04 | $13K |
| 99305 SNF E&M | Office | 69 | 65 | $87.75 | $6,055 |
| 99310 SNF E&M | Facility | 51 | 40 | $106.31 | $5,422 |
| 99309 SNF E&M | Facility | 37 | 33 | $71.21 | $2,635 |
| 99305 SNF E&M | Facility | 13 | 13 | $98.12 | $1,276 |
By year: 2022 $35K for 267 services; 2023 $49K for 476 services; 2024 $91K for 931 services.
Medicare prescription drug claims, 2024
In 2024, the drug Desire T Gijima prescribed most often to Medicare patients was Eliquis (Apixaban), with 649 prescriptions and refills. In total Desire T Gijima wrote 14,933 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 649 | 649 | 56 | $186K |
| Furosemide Generic | 510 | 517 | 95 | $3,996 |
| Sertraline Hcl Generic | 472 | 480 | 65 | $6,645 |
| Levothyroxine Sodium Generic | 450 | 457 | 83 | $6,631 |
| Jardiance Empagliflozin | 430 | 430 | 39 | $125K |
| Metoprolol Succinate Generic | 406 | 413 | 65 | $8,516 |
| Lisinopril Generic | 405 | 411 | 72 | $4,008 |
| Gabapentin Generic | 394 | 400 | 65 | $8,837 |
| Amlodipine Besylate Generic | 381 | 387 | 66 | $3,752 |
| Atorvastatin Calcium Generic | 368 | 374 | 79 | $6,710 |
| Potassium Chloride Generic | 326 | 331 | 54 | $9,412 |
| Pantoprazole Sodium Generic | 325 | 330 | 58 | $4,934 |
| Trazodone Hcl Generic | 261 | 265 | 50 | $3,342 |
| Duloxetine Hcl Generic | 260 | 264 | 37 | $7,380 |
| Lantus Insulin Glargine,hum.Rec.Anlog | 246 | 246 | 38 | $20K |
Brand drugs: 3,002 claims; generic drugs: 11,888 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Desire T Gijima $87.49 ($87.49 in general payments such as food, travel and fees) from 1 company. The largest payer was Teva Pharmaceuticals USA, Inc. with $87.49.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $87.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.